§ 7-304. Review criteria for pain medication licenses.

An application for a pain medication license shall be submitted to the director of community development. The development review committee shall review the application, based on the criteria of this subsection and consistency of the application with the public health, safety, and welfare of the city, and shall make a recommendation to the director of community development. The director shall prepare a report to the city commission recommending approval, approval with conditions, or denial, based upon the following criteria:

(a)

The amount and degree of law enforcement activities generated by the operation of any such establishment, by previous similar establishments in the same location or at any location involving any of the same owners or operators. Consideration will be given as to whether the calls are initiated by the pain medication license holder and what efforts have been taken to reduce unlawful activity at establishments owned or operated by the applicant;

(b)

A criminal background check of all owners or operators or any other party with a proprietary interest in such establishment shall be conducted in order to provide assurances that such persons have no criminal convictions, including but not limited to convictions under F.S. Ch. 893 within the last ten (10) years;

(c)

The adverse effects of prescribing, storing, and/or dispensing schedule II substances shall not place an undue burden on the neighborhood in proximity to the establishment, especially with respect to patron activities and effects of noise, traffic, parking, and vehicular use; and

(d)

Compatibility with the existing uses in the neighborhood in proximity to the establishment.

(e)

The amount and degree of security measures in place including but not limited to: impact resistant glass, exterior lighting, security cameras, video recordings, alarm and panic system, crime prevention through environmental design ("CPTED") standards, principals, and signage.

(Ord. No. 512-11-B, § 3, 6-28-11)